Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

BRIDGEBIO PHARMA

Filed by MARSHALL & POPP, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
Registration
Posted
Jul 10, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
b8df9640-245b-4595-bf59-062028bc2345
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs.

MMM · Medicare/Medicaid

Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs.

TAX · Taxation/Internal Revenue Code

Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs.

BUD · Budget/Appropriations

Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.